Literature DB >> 10499183

Comparing primary and secondary generalized anxiety disorder in a long-term naturalistic study of anxiety disorders.

M P Rogers1, M G Warshaw, R M Goisman, I Goldenberg, F Rodriguez-Villa, G Mallya, S A Freeman, M B Keller.   

Abstract

This study explores the potential differences in comorbidity and course between primary generalized anxiety disorder (GAD), which develops before other anxiety disorders, and secondary GAD. As part of the Harvard/Brown Anxiety Research Project (HARP), a naturalistic, long-term, longitudinal study of 711 subjects from a variety of clinic settings with DSM III-R defined anxiety disorders, 210 subjects with GAD were identified. Of these, 78 (37%) had primary GAD, and 84 (40%) had secondary GAD; of the remainder, 28 (13%) had no other anxiety disorder and 20 (10%) developed GAD within a month of another anxiety disorder and were excluded from the analysis. All subjects were comorbid for at least one other anxiety disorder. Primary GAD subjects were more likely to be in episode at intake (90% vs. 77%, P = .04) and less likely than secondary GAD subjects to have current or past agoraphobia without panic disorder (3% vs. 11%, P = .04), social phobia (19% v. 52%, P = .001), simple phobia (14% v. 30%, P = .02), or post traumatic stress disorder (5% vs. 20%, P = .01). Subjects with primary GAD were also less likely to have current or past alcohol use disorders (17% vs. 37%, P = .004) or major depressive disorder (60% vs. 76%, P = .03). There were no significant differences in either treatment approaches or remission rates for primary compared to secondary GAD. Whether GAD first occurs before or after another anxiety disorder, it is similar in terms of prevalence, treatment, and course. The only significant differences between primary and secondary GAD lie in the rates of comorbidity of both other anxiety disorders and non-anxiety disorders, including major depression and substance abuse. These results support the concept of GAD as a valid, separate and distinct entity, whether it occurs primarily or secondarily.

Entities:  

Mesh:

Year:  1999        PMID: 10499183

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  6 in total

1.  Diagnostic comorbidity in adults with generalized anxiety disorder: impact of comorbidity on psychotherapy outcome and impact of psychotherapy on comorbid diagnoses.

Authors:  Michelle G Newman; Amy Przeworski; Aaron J Fisher; Thomas D Borkovec
Journal:  Behav Ther       Date:  2009-06-08

2.  Developmental course of anxiety and depression from adolescence to young adulthood in a prospective Norwegian clinical cohort.

Authors:  Ingunn Ranøyen; Stian Lydersen; Tricia L Larose; Bernhard Weidle; Norbert Skokauskas; Per Hove Thomsen; Jan Wallander; Marit S Indredavik
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-03-03       Impact factor: 4.785

3.  Generalized anxiety disorder and health care use.

Authors:  Lynda Bélanger; Robert Ladouceur; Charles M Morin
Journal:  Can Fam Physician       Date:  2005-10       Impact factor: 3.275

4.  Childhood behavioral inhibition and attachment: Links to generalized anxiety disorder in young adulthood.

Authors:  Magdalena A Zdebik; Katherine Pascuzzo; Jean-François Bureau; Ellen Moss
Journal:  Front Psychol       Date:  2022-09-06

5.  Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder.

Authors:  Jean Endicott; Henrik Svedsäter; Julie C Locklear
Journal:  Neuropsychiatr Dis Treat       Date:  2012-07-11       Impact factor: 2.570

Review 6.  Environmental transmission of generalized anxiety disorder from parents to children: worries, experiential avoidance, and intolerance of uncertainty.

Authors:  Evin Aktar; Milica Nikolić; Susan M Bögels
Journal:  Dialogues Clin Neurosci       Date:  2017-06       Impact factor: 5.986

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.